Meds Apotek stock
Meds Apotek was founded in 2018 by Adham, Joanna and Björn, three entrepreneurs with extensive experience in the pharmacy industry and e-commerce. Headquartered in Stockholm, Meds is a full-scale digital pharmacy that sells prescription and over-the-counter medicines authorised by the Swedish Medical Products Agency. Meds has no physical stores but focuses on delivering products directly to customers as quickly as possible.
Meds Apotek share price
Current bids and asks, the latest trade and Meds Apotek's valuation. The full price history opens once you create an account.
Account required
See the full price history
Complete transaction history, order depth and valuation data are free once you open an account.
Create accountOther companies you may be interested in
-400x300.png&w=3840&q=75)
-400x300.png&w=3840&q=75)
Note: Share price is from each company's latest known share issue. The change compares it with the previous issue and does not account for splits or differing share classes.
Meds Apotek new issues and valuations
| Date | Type | Share price | Valuation The company's valuation after the funding round was completed (Post-money). | Amount The specific amount raised in this funding round. |
|---|---|---|---|---|
| Q2 2023 | Share issuance | 44 SEK | SEK 759,100,000 | Locked |
| Q2 2022 | Share issuance | 80 SEK | SEK 1,262,300,000 | Locked |
| Q1 2021 | Share issuance | 48.6 SEK | SEK 763,000,000 | Locked |
See the amount raised in every funding round
Free · about two minutes
Note: Information on Meds Apotek's funding rounds, amounts, and valuation is sourced from news media and public sources unless otherwise stated. Information on capital structure is sourced from public company registers unless otherwise stated.
Buy or sell Meds Apotek shares
Place a bid or a sell order. Accumeo matches you with the counterparty and handles the transfer through an established process.
Create accountFree · about two minutes
Unsure about the price picture in Meds Apotek, or sitting on a larger holding? Book fifteen minutes with the desk before you place an order.
Book a callReply within one business day
Have any questions about buying or selling shares in private companies? Don't hesitate to contact us.
How trading works
From account to completed transfer
1. Create an account
Identification is handled with BankID. The account is free and carries no obligation to trade.
2. Study the company
Price history, completed trades, ownership and documents gathered in one place.
3. Place your order
State the number of shares, the price and any conditions. Your order is anonymous to the market.
4. We handle settlement
On a match we draw up a share transfer agreement covering price, share count and closing date.
Settlement follows an established process with third-party verification of payment and share transfer, minimizing counterparty risk for both parties.
What an account unlocks
Every completed transaction in Meds Apotek, with date and price per share.
The order book's price picture, updated in real time.
Largest owners, annual reports and issue terms.
A notice when new interest is registered or the price moves.
Meds Apotek was founded in 2018 by Adham, Joanna and Björn, three entrepreneurs with extensive experience in the pharmacy industry and e-commerce. Headquartered in Stockholm, Meds is a full-scale digital pharmacy that sells prescription and over-the-counter medicines authorised by the Swedish Medical Products Agency. Meds has no physical stores but focuses on delivering products directly to customers as quickly as possible.
Note: Information on Meds Apotek is sourced from official channels and public sources unless otherwise stated.
Major Shareholders in Meds Apotek
| Owner | Share |
|---|---|
| M2 Asset Management AB | 14.57 % |
| Coeli Wealth Management AB | 9.91 % |
| Ilija Batljan Invest AB | 5.26 % |
| Bjorn Thorngren | 4.02 % |
| CNI Nordic 5 AB | 4.00 % |
Source: Eivora (9/5/2025) · Information on Meds Apotek's ownership structure is sourced from public company registers and external data providers unless otherwise stated.
Meds Apotek key figures
No key figures available.
Interested in Meds Apotek shares?
Create an account to see completed trades and order depth, or call us if you would rather talk through the price picture first.
News about Meds Apotek
Meds tecknar nytt logistikavtal
Meds Apotek kommer att flytta in i en ny logistikfastighet i Eskilstuna i augusti, vilket tredubblar deras lagerstorlek. Arena Personal kommer att sköta driften och bemanningen av det nya logistikcentrumet.
Han lovar en miljon kronor – till den som vill ta över Meds gamla lager
Nätapoteket Meds utlovar en miljon kronor i hittelön till den som kan ta över deras gamla lagerlokaler efter flytten till nya, större utrymmen.
Meds Apotek vill fortsätta växa snabbare än marknaden - vd
FAQ
Meds Apotek is an unlisted company, meaning the shares are not traded on any exchange. Instead, transactions take place through direct transfers between parties, known as secondary trading, typically via a specialised platform for unlisted shares such as Accumeo. For larger international companies, investing through fund structures that pool several investors into a single ownership vehicle is also common. This allows smaller minimum investments and opens up access to international companies for non-institutional investors.
Yes, it is possible to buy existing shares in Meds Apotek through secondary trading. On Accumeo you create a free account, submit an expression of interest with an amount and any conditions, and may then be matched with a seller. Once both parties have signed the customer agreement, a share transfer agreement is drawn up covering price, share count, and settlement date.
Yes, secondary trading is often the only realistic route to liquidity for an unlisted holding before an IPO or acquisition. Via Accumeo you submit an expression of interest with a share count and target price, and a match may be made with a potential buyer. The sale is executed through a share transfer agreement and registered either via Euroclear or directly in the company's share register, depending on how ownership is administered.
Unlisted companies have no continuous share price because there is no continuous exchange trading. The value is instead based on the latest secondary-market trade or on the price per share from the most recent share issuance. Accumeo shows both historical transaction prices and current bid/ask quotes, providing a combined reference point for pricing.
The value of an unlisted share is most often based on the latest trade — the price buyer and seller agreed in a transaction — or on the latest funding round, where the company and its investors agreed a price for the newly issued shares. These are the reference points shown on Accumeo's platform. It is, however, important to form your own view of value by examining the company's prospects. Financial reports, growth opportunities, market position, and comparable transactions in the sector all help to build a better picture of how the business may develop. Useful information can be found on the company's own website, via Accumeo's platform, and on services like allabolag.se.
No, Meds Apotek is an unlisted company and its shares are not traded on the Stockholm Stock Exchange, NYSE, or any other regulated marketplace. Shares are instead traded through secondary trading between investors, typically via a specialised platform such as Accumeo.
Yes. Shares in Meds Apotek can be delivered to an ordinary securities account with a broker such as Avanza or Nordnet, and are registered as the transaction completes.
We hold no registered transfer restrictions for Meds Apotek. The articles of association are what decide this, so read them before placing an order — restrictions can be added without showing up in public sources.
Disclaimer: The information in this FAQ is provided for informational purposes only and does not constitute an offer to buy or sell securities, a solicitation of such an offer, or investment advice. Accumeo has no commercial relationship with the companies whose securities are mentioned. Independent advice should be obtained before making any investment decision.
Start exploring unlisted shares today
Join 5,000+ investors already trading unlisted shares. Create an account in 2 minutes with BankID — completely free.